ANLN and breast cancer: ANLN is overexpressed in different tumor types, including breast cancer (Downs et al., 2019), lung cancer (Suzuki et al., 2005; Deng et al., 2021), pancreatic cancer (Idichi et al., 2017; Wang et al., 2019), liver cancer (Lian et al., 2018), bladder cancer (Zeng et al., 2017), and colorectal cancer (Wang et al., 2016).